Dutch Colorectal Cancer Group   Report issue

Academic/Hospital Phase 3
Founded: Amsterdam Netherlands (2001)

Organization Overview

First Clinical Trial
2003
NCT00312000
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dutch Colorectal Cancer Group | Dutch Colorectal Cancer Group (DCCG)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 3)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 3)

Liver Neoplasms (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms, Second Primary (Phase 3)

Recurrence (Phase 3)

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 15